Preservation of insulin secretory responses to P2 purinoceptor agonists in Zucker diabetic fatty rats

Am J Physiol. 1996 Mar;270(3 Pt 1):E504-12. doi: 10.1152/ajpendo.1996.270.3.E504.

Abstract

The role of P2 purinoceptor agonists in regulatory insulin secretion in Zucker diabetic fatty (ZDF) rats was studied using the isolated perfused pancreas and intracellular Ca2+ concentration ([Ca2+]i) microfluorimetry. The relative potency of different purinoceptor agonists to stimulate the insulin secretory process was consistent with the conclusion that responses in [Ca2+]i and insulin secretion are mediated by the P2y subtype of purinoceptors. Additional studies using specific antagonists of the Ca2+ signaling pathway indicated that activation of P2y purinoceptor releases Ca2+ from intracellular stores and promotes Ca2+ entry through voltage-independent rather than voltage-dependent Ca2+ channels on the beta-cell membrane. Perfused pancreas and isolated islets from ZDF rats demonstrated markedly reduced or absent insulin secretion and [Ca2+]i responses to glucose and KCl. In contrast, responses to P2y purinoceptor agonists were normal, indicating that the secretion coupling pathway activated by these agonists is preserved in glucose-unresponsive islets from diabetic animals. These observations raise the possibility that the purinoceptor pathway may play an important role in regulating insulin secretion in hyperinsulinemic non-insulin-dependent diabetes mellitus.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine / pharmacology
  • Adenosine Diphosphate / analogs & derivatives
  • Adenosine Diphosphate / pharmacology
  • Adenosine Monophosphate / pharmacology
  • Adenosine Triphosphate / analogs & derivatives*
  • Adenosine Triphosphate / pharmacology*
  • Analysis of Variance
  • Animals
  • Blood Glucose / metabolism
  • Body Weight
  • Calcium / metabolism
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / physiopathology*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / physiopathology*
  • In Vitro Techniques
  • Insulin / blood
  • Insulin / metabolism*
  • Insulin Secretion
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism*
  • Kinetics
  • Male
  • Obesity*
  • Perfusion
  • Potassium Chloride / pharmacology
  • Purinergic P2 Receptor Agonists*
  • Rats
  • Rats, Wistar
  • Rats, Zucker
  • Reference Values
  • Thionucleotides / pharmacology
  • Time Factors

Substances

  • Blood Glucose
  • FPL 66301
  • Insulin
  • Purinergic P2 Receptor Agonists
  • Thionucleotides
  • adenosine 5'-O-(2-thiodiphosphate)
  • Adenosine Monophosphate
  • Adenosine Diphosphate
  • Potassium Chloride
  • Adenosine Triphosphate
  • Adenosine
  • Calcium